Daniel Lenihan

11PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 15, 2026
Medical strategies of cardiovascular protection to reduce cancer therapy-related cardiovascular toxicity: where do we stand?

|Feb 13, 2026
Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple Myeloma.

Raed Awadh Alshammari, Samuel M Rubinstein, Eric Farber-Eger

|Feb 02, 2026
Causal Effects of Hydrophilic Bile Acids on Carfilzomib-Related Cardiovascular Events in Multiple Myeloma: A Mendelian Randomization Study.

Samia Shabnaz, Eric Farber-Eger, Marwa Tantawy

|Sep 22, 2025
Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosis.

Kristine H Jang, Anthony F Yu, Heather Landau

|Aug 14, 2025
Myocardial Strain Measurements Obtained with Fast-Strain-Encoded Cardiac Magnetic Resonance for the Risk Prediction and Early Detection of Chemotherapy-Related Cardiotoxicity Compared to Left Ventricular Ejection Fraction.

Daniel Lenihan, James Whayne, Farouk Osman

|Jul 27, 2024
Differential Expression of Circulating miRNAs and Carfilzomib-Related Cardiovascular Adverse Events in Patients with Multiple Myeloma.

Marwa Tantawy, Taimour Langaee, Danxin Wang

Pageof 2

Frequent Collaborators

3 joint publications

Yan Gong

2 joint publications

Rachid C Baz

2 joint publications

Eric Farber-Eger

2 joint publications

Joshua D Mitchell